前药
化学
阿霉素
结合
药物输送
共轭体系
乙二醇
生物物理学
纳米颗粒
纳米载体
靶向给药
毒品携带者
体内
细胞毒性
内吞作用
内化
生物化学
组合化学
胶束
癌症研究
叶酸受体
PEG比率
药理学
体内分布
体外
化疗
细胞
医学
生物
外科
有机化学
财务
经济
作者
Daniela Guarnieri,Marco Biondi,Hui Yu,Valentina Belli,Andrea Patrizia Falanga,Marco Cantisani,Stefania Galdiero,Paolo A. Netti
摘要
A major issue in chemotherapy is the lack of specificity of many antitumor drugs, which cause severe side effects and an impaired therapeutic response. Here we report on the design and characterization of model tumor activated prodrug-conjugated polystyrene (PS) nanoparticles (TAP-NPs) for the release of doxorubicin (Dox) triggered by matrix metalloprotease-2 (MMP2) enzyme, which is overexpressed in the extracellular matrix of tumors. In particular, TAP-NPs were produced by attaching Dox to poly(ethylene glycol) (PEG) through two MMP2—cleavable enzymes. The resulting adduct was then tethered to PS NPs. Results showed that Dox release was actually triggered by MMP2 cleavage and was dependent on enzyme concentration, with a plateau around 20 nM. Furthermore, significant cell cytotoxicity was observed towards three cell lines only in the presence of MMP2, but not in cells without enzyme pre-treatment, even after NP internalization by cells. These findings indicate the potential of TAP-NPs as suitable nanocarriers for an on demand, tumor—specific delivery of antitumor drugs after the response to an endogenous stimulus. Further advancements will focus on the translation of this production technology to biodegradable systems for the safe transport of cytotoxic drug to tumor tissues. Biotechnol. Bioeng. 2015;112: 601–611. © 2014 Wiley Periodicals, Inc.
科研通智能强力驱动
Strongly Powered by AbleSci AI